Jia You

Jia You

Auto-generated profile, based on publicly available information

Jia You

Department of Neurology and National Center for Neurological Disorders, Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Shanghai Medical College, Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2024 in Nature Aging
Verified
Journal Article
Closed access
PDF file
YGYu Guo
Yu Guo
JYJia You
Jia You
YZYi Zhang
Yi Zhang
WLWei-Shi Liu
Wei-Shi Liu
YHYu-Yuan Huang
Yu-Yuan Huang
JYJintai Yu
Jintai Yu

28 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JYJia You
Jia You
YGYu Guo
Yu Guo
YZYi Zhang
Yi Zhang
JKJu-Jiao Kang
Ju-Jiao Kang
林王林波 王
林波 王
JYJintai Yu
Jintai Yu
Developing a single-domain assay to identify individuals at high risk of future events is a priority for multi-disease and mortality prevention. By training a neural network, we developed a disease/mortality-specific proteomic risk score (ProRS) based on 1461 Olink plasma proteins measured in 52,006 UK Biobank participants. This integrative score markedly stratified the risk for 45 common conditions, including infectious, hematological, endocrine, psychiatric, neurological, sensory, circulatory, respiratory, digestive, cutaneous, musculoskeletal, and genitourinary diseases, cancers, and mortality. The discriminations witnessed high accuracies achieved by ProRS for 10 endpoints (e.g., cancer, dementia, and death), with C-indexes exceeding 0.80. Notably, ProRS produced much better or equivalent predictive performance than established clinical indicators for almost all endpoints. Incorporating clinical predictors with ProRS enhanced predictive power for most endpoints, but this combination only exhibited limited improvement when compared to ProRS alone. Some proteins, e.g., GDF15, exhibited important discriminative values for various diseases. We also showed that the good discriminative performance observed could be largely translated into practical clinical utility. Taken together, proteomic profiles may serve as a replacement for complex laboratory tests or clinical measures to refine the comprehensive risk assessments of multiple diseases and mortalities simultaneously. Our models were internally validated in the UK Biobank; thus, further independent external validations are necessary to confirm our findings before application in clinical settings.

9 December 2024 in Nature Aging
Verified
Journal Article
Closed access
PDF file
WLWei-Shi Liu
Wei-Shi Liu
JYJia You
Jia You
SCShi-Dong Chen
Shi-Dong Chen
YZYi Zhang
Yi Zhang
JFJianfeng Feng
Jianfeng Feng
CWCheng Wei
Cheng Wei

27 April 2023 in Stroke and Vascular Neurology
Verified
Journal Article
Open access
PDF file
JYJia You
Jia You
YGYu Guo
Yu Guo
JKJu-Jiao Kang
Ju-Jiao Kang
HWHui-Fu Wang
Hui-Fu Wang
MYMing Yang
Ming Yang
CWCheng Wei
Cheng Wei
Background Previous prediction algorithms for cardiovascular diseases (CVD) were established using risk factors retrieved largely based on empirical clinical knowledge. This study sought to identify predictors among a comprehensive variable space, and then employ machine learning (ML) algorithms to develop a novel CVD risk prediction model. Methods From a longitudinal population-based cohort of UK Biobank, this study included 473 611 CVD-free participants aged between 37 and 73 years old. We implemented an ML-based data-driven pipeline to identify predictors from 645 candidate variables covering a comprehensive range of health-related factors and assessed multiple ML classifiers to establish a risk prediction model on 10-year incident CVD. The model was validated through a leave-one-center-out cross-validation. Results During a median follow-up of 12.2 years, 31 466 participants developed CVD within 10 years after baseline visits. A novel UK Biobank CVD risk prediction (UKCRP) model was established that comprised 10 predictors including age, sex, medication of cholesterol and blood pressure, cholesterol ratio (total/high-density lipoprotein), systolic blood pressure, previous angina or heart disease, number of medications taken, cystatin C, chest pain and pack-years of smoking. Our model obtained satisfied discriminative performance with an area under the receiver operating characteristic curve (AUC) of 0.762±0.010 that outperformed multiple existing clinical models, and it was well-calibrated with a Brier Score of 0.057±0.006. Further, the UKCRP can obtain comparable performance for myocardial infarction (AUC 0.774±0.011) and ischaemic stroke (AUC 0.730±0.020), but inferior performance for haemorrhagic stroke (AUC 0.644±0.026). Conclusion ML-based classification models can learn expressive representations from potential high-risked CVD participants who may benefit from earlier clinical decisions.

10 July 2024 in Nature Human Behaviour
Verified
Journal Article
Closed access
PDF file
YGYu Guo
Yu Guo
SCShi-Dong Chen
Shi-Dong Chen
JYJia You
Jia You
SHShu-Yi Huang
Shu-Yi Huang
YCYi-Lin Chen
Yi-Lin Chen
JYJintai Yu
Jintai Yu

20 February 2025 in Nature Aging
Verified
Journal Article
Closed access
PDF file
YGYi-Han Gan
Yi-Han Gan
LMLing-Zhi Ma
Ling-Zhi Ma
YZYi Zhang
Yi Zhang
JYJia You
Jia You
YGYu Guo
Yu Guo
JYJintai Yu
Jintai Yu